# Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis

> **NCT05359497** · NA · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 50 (estimated)

## Conditions studied

- PSC
- MRI

## Interventions

- **DIAGNOSTIC_TEST:** Liver Multiscan sequences baseline
- **DEVICE:** MRCP+ analysis baseline
- **DEVICE:** Liver Multiscan analysis baseline
- **DIAGNOSTIC_TEST:** MRI liver with MRCP
- **DIAGNOSTIC_TEST:** Liver Multiscan sequences follow-up
- **DEVICE:** MRCP+ analysis follow up
- **DEVICE:** Liver Multiscan analysis follow up

## Key facts

- **NCT ID:** NCT05359497
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-05
- **Final completion:** 2023-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05359497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05359497, "Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05359497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*